Biosensors are changing how we monitor health, but rapid innovation raises tough questions around privacy, regulation, and access. This article breaks down the key issues shaping their future.

Orthocell receives US FDA 510(k) approval for Remplir, its flagship nerve repair product and can now start commercial ...

Explore the KeratOPrinter project, an innovative solution to corneal shortages using advanced bioprinting technology.

Nearly 10 Product Candidates Under Development are Expected to be Commercialized in the Next Three YearsHONG KONG, Apr 1, 2025 - (JCN Newswire) - Cryofocus Medtech (Shanghai) Co., Ltd. ('Cryofocus Med ...

All DIs in TN are fully competent to inspect manufacturing units as per Revised Schedule M: MN Sridhar: Monday, March 31, ...

Startup iPixel aims to bridge the physical and digital gap in exercise and physical therapy with its AI-powered motion ...

In June 2024, Junshi Biosciences convened the 2023 annual general meeting, the 2024 first class meeting of A shareholders and the 2024 first class meeting of H shareholders, and completed the election ...

In the second half of 2024, Langhua Pharmaceutical has undergone the on-site inspection by the FDA which covered six major systems, namely, quality system, materials, production, packaging and ...

Micro, small and medium enterprises (MSMEs) with revenue of less than ₹ 250 crore have to submit an application before the ...

Older dogs and cats represent the largest at-risk group in animal shelters, with only 25% of senior dogs finding new forever homes. They can spend four times longer in shelters than young dogs and ...

Benuvia Operations, LLC (Benuvia), a global contract development and manufacturing organization, today announced that it has been awarded a five-year contract by the National Institute on Drug Abuse ...